A Study of Subcutaneous Mircera in Patients With Chronic Kidney Disease, Not on Dialysis.

NCT00442702 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

228

Enrollment

INDUSTRY

Sponsor class

Conditions

Anemia

Interventions

DRUG: Mircera
DRUG: Darbepoetin alfa

Sponsor

Hoffmann-La Roche